Faculdade de Medicina da Universidade Federal de Minas Gerais

SIGMA LITHIUM PROMOTES KEY DIRECTORS TO CO-GENERAL MANAGERS REWARDING THEIR SIGNIFICANT OPERATIONAL ACHIEVEMENTS

Retrieved on: 
Friday, October 6, 2023
Lithium, Business, MS, Keith Prentice, Norsk Hydro, South Dakota School of Mines and Technology, Resource, Extractive metallurgy, Mining, Operations director, Yamana Gold, Vale, USP, Vallourec, Federal University of Ouro Preto, Sierra Rutile Limited, ESG, School, University, Faculdade de Medicina da Universidade Federal de Minas Gerais, Universidade Estadual do Maranhão, Process, Metallurgy, Mine, University of Johannesburg, Forecasting, Doctor of Philosophy, Family, Culture, SAO, Carbon, Specialised Technical Committees of the African Union, Greentech, De Beers, Management, Electric battery, Rare-earth element, Tutoring, Geology, Engineering

The elevation of co-General Managers has had a positive operational impact to Sigma Lithium.

Key Points: 
  • The elevation of co-General Managers has had a positive operational impact to Sigma Lithium.
  • He has had multiple internal key leadership roles including Senior Geologist, Operational Director, Director of Regional Institutional Relations, and Head of Geology.
  • Mr. Talbot's departure and extended personal leaves since June have not brought any operational impact to Sigma Lithium.
  • Cesar Chicayban, Lead Independent Director of Sigma Lithium said: "CEO Ana Cabral and her co-general managers have delivered impeccably, surpassing every operational milestone.

Uvax Bio Appoints Pedro Garbes, MD., as Vice President, Global Medical Lead

Retrieved on: 
Wednesday, September 13, 2023
Science, Biotechnology, Research, Pharmaceutical, AIDS, Health, Infectious Diseases, Clinical Trials, Vaccine, GSK plc, University, Senior, HIV, Bio, FISU World University Games, HIV-1, Allergan, COVID-19, Infection, Global health, AstraZeneca, Messenger, Administration, Sanofi Pasteur, Faculdade de Medicina da Universidade Federal de Minas Gerais, Gritstone bio, VLP, Rest, Virus, Master, Medicine

Uvax Bio LLC, a vaccine biotechnology company that utilizes its proprietary 1c-SApNP® vaccine design and manufacturing platform to produce protein-based VLP vaccines to fight viruses that threaten global health, announced today that Pedro Garbes, MD., has joined the company as Vice President, Global Medical Lead.

Key Points: 
  • Uvax Bio LLC, a vaccine biotechnology company that utilizes its proprietary 1c-SApNP® vaccine design and manufacturing platform to produce protein-based VLP vaccines to fight viruses that threaten global health, announced today that Pedro Garbes, MD., has joined the company as Vice President, Global Medical Lead.
  • Dr. Garbes joins Uvax Bio at a key inflection point as the company’s recombinant protein nanoparticle vaccines are advancing in development.
  • "We are pleased to have Pedro join our leadership team as we prepare to take our lead vaccines to the next stage of development.
  • Pedro Garbes brings to Uvax Bio over two decades of life sciences experience in clinical vaccine development, medical affairs, and medical/commercial strategy.

Elizabeth Camargo, AIA, Elected 2025 AIA Florida President

Retrieved on: 
Wednesday, August 2, 2023
Odyssey, STAC, Volunteering, University of Utah College of Architecture and Planning, University, USF, FISU World University Games, Licensure, Rio Grande, Mind, File association, Florida Association of Band Directors, Associate, Camargo, JLI, Faculdade de Medicina da Universidade Federal de Minas Gerais, Biophysical environment, Ethics, Professional practice of behavior analysis, EC, Women in architecture, Woman, American Institute, AIA, Massachusetts Institute of Technology, Interior design, Management, Science, Architecture

ORLANDO, Fla., Aug. 2, 2023 /PRNewswire/ -- The Florida Association of the American Institute of Architects (AIA Florida) has elected Elizabeth Camargo, AIA, as its president for 2025.

Key Points: 
  • ORLANDO, Fla., Aug. 2, 2023 /PRNewswire/ -- The Florida Association of the American Institute of Architects (AIA Florida) has elected Elizabeth Camargo, AIA, as its president for 2025.
  • AIA, Associate Director at-Large – Hughes served the AIA Florida Southwest board as an associate at-large for Women in Architecture.
  • Camargo will join the 2024 board led by AIA Florida President Rhonda Hammond, AIA, in January.
  • They will serve the organization along with Immediate Past President Beverly Frank, AIA, Secretary/Treasurer Joshua Skatkin, AIA, and Vice Presidents Adam Gayle, AIA, and Kelly Wieczorek, AIA, and the 13 state directors from AIA Florida's local components.

Quanta Therapeutics Appoints Leonardo Faoro, MD, as Chief Medical Officer

Retrieved on: 
Tuesday, December 13, 2022
Prostate, Master's degree, Universiade, Protein, Drug discovery, Neoplasm, Breast, SAN, Mayo Clinic, FDA, RAS, Cancer, General of the branch, Chicago (franchise), Columbia University, Doctor of Philosophy, Bevacizumab, Genentech, MD, Internal medicine, Drug development, Lung, SHG, Growth, Faculdade de Medicina da Universidade Federal de Minas Gerais, Business administration, Research, Mutation, Therapy, University of California, Berkeley, OncoMed, Senior, University, Clinical professor, Patient, KRAS, Pharmaceutical industry, Cabozantinib, Quanta, Exelixis

SOUTH SAN FRANCISCO, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held biopharmaceutical company pioneering complex-directed therapies to treat RAS-driven cancer types, today announced the appointment of Dr. Leonardo Faoro as Chief Medical Officer. Dr. Faoro brings more than 13 years of global clinical and regulatory experience advancing oncology medicines from early development stages through to approval, most recently serving as Senior Vice President and Early Clinical Development Lead at Exelixis, where he provided strategic leadership to expand the company's early clinical oncology pipeline and advance development candidates into the clinic.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Quanta Therapeutics, a privately-held biopharmaceutical company pioneering complex-directed therapies to treat RAS-driven cancer types, today announced the appointment of Dr. Leonardo Faoro as Chief Medical Officer.
  • “We have made tremendous progress in advancing our novel RAS-targeted discovery programs with a unique focus on disrupting the active RAS signaling complex,” said Perry Nisen, MD, PhD, Chief Executive Officer of Quanta Therapeutics.
  • Quanta Therapeutics aims to advance two differentiated, next-generation RAS programs that address the resistance paradigms of targeted therapy in oncology.
  • Quanta Therapeutics is a private biopharmaceutical company focused on the most prevalent and elusive target in oncology—RAS.

START Center for Cancer Care to Open New Locations in Lisbon and Dublin

Retrieved on: 
Tuesday, November 15, 2022
University, Education, Health, Pharmaceutical, Oncology, Training, Research, Hospitals, Science, Clinical Trials, Continuing, FDA, Mater Misericordiae University Hospital, Mater, CHLN, Hospital de São José, Cancer, Research, Instituto de Medicina Molecular, START, Mater Hospital Pimlico, Hospital de Santa Maria, Sister, Union, Faculdade de Medicina da Universidade Federal de Minas Gerais, University College Dublin, The Sisters of Mercy, Hospital, Patient, Pharmaceutical industry, Medicine

The START Center for Cancer Care , a San Antonio-based oncology early-phase clinical research site network, will open Portugals first facility in Lisbon in late 2022 and is slated to open Irelands first early-phase clinical research facility in Dublin in early 2023.

Key Points: 
  • The START Center for Cancer Care , a San Antonio-based oncology early-phase clinical research site network, will open Portugals first facility in Lisbon in late 2022 and is slated to open Irelands first early-phase clinical research facility in Dublin in early 2023.
  • For Lisbon, the principal investigator had previously trained at the START training program in START Madrid.
  • START Center operates six existing locations across the U.S. and Spain, which makes it one of the largest early-phase clinical research sites in the world.
  • The dedication to finding and developing the best cancer treatments drives each of us, START Center President and Founder Lon S. Smith, M.D.

NN, Inc. Announces Executive Team Transition

Retrieved on: 
Tuesday, November 1, 2022
Security (finance), Goal, Growth, NN, Board of directors, CEO, Climate change, COVID, Leadership, U.S. Securities and Exchange Commission, General manager, Korn Ferry, GLOBE, Solution, Board, PEP group translocation, Worcester Polytechnic Institute, COVID-19, Commercial, Engineering, Faculdade de Medicina da Universidade Federal de Minas Gerais, Business, Phrase, Group, Kellogg School of Management, University, Chemical engineering, Acquisition, NASDAQ, University of Massachusetts, Company, Universiade, Kellogg School, Forward-looking statement, Risk, Management, Science

NN anticipates that Mr. Veltman and Mr. Buchan will remain in their current positions until March 31, 2023, which may be extended in order to facilitate an orderly transition.

Key Points: 
  • NN anticipates that Mr. Veltman and Mr. Buchan will remain in their current positions until March 31, 2023, which may be extended in order to facilitate an orderly transition.
  • Following their respective retirements, the Company expects that Mr. Veltman and Mr. Buchan will remain available on a consulting basis to assist with the management transition as needed.
  • Each will report to John Buchan to facilitate a smooth transition and continuity of operational leadership.
  • We have accomplished much over the past three plus years as we positioned NN for sustainable long-term growth and improved operating performance.

Altair Announces Future.Industry 2022 Global Flagship Event

Retrieved on: 
Thursday, September 15, 2022
Cloud, Cloud computing, Intel, Software, ALTR, JCB, Digital, Central European, Digital transformation, Engineering, CEST, Columbia University, Industry, EDT, University, Organization, Leonardo S.p.A., Temple University, Pirelli, Moon, Google Cloud, Translation, Digital twin, Nelson Mandela University, Technology, Tech Mahindra, Lucid Motors, Purdue University, Solution, ArcelorMittal, Artificial intelligence, Fly Me to the Moon, Science, High Performance Computing Modernization Program, Central European Forum, Transformation, AMD, Physics, HPC, AI, Faculdade de Medicina da Universidade Federal de Minas Gerais, Universiade, Medical device, Management, Nissan, Belcan, TROY

TROY, Mich., Sept. 15, 2022 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational science and artificial intelligence (AI), is thrilled to announce the launch of Future.Industry 2022, the company's flagship annual event. From big brand thought leaders to early-stage startup entrepreneurs, the event will feature some of the industry's brightest minds and leading organizations as they discuss the latest trends, innovations, and forecasts in simulation, high-performance computing (HPC), AI, and data analytics technology.

Key Points: 
  • Virtual event will feature international speakers discussing the latest technology, tools, and trends in computational science
    TROY, Mich., Sept. 15, 2022 /PRNewswire/ -- Altair (Nasdaq: ALTR), a global leader in computational science and artificial intelligence (AI), is thrilled to announce the launch of Future.Industry 2022 , the company's flagship annual event.
  • Additionally, attendees will have the chance to win Altair merchandise and e-gift cards by attending the event.
  • To learn more about Future.Industry 2022 or to register for the event, visit https://events.altair.com/future-industry/.
  • Altair is a global leader in computational science and artificial intelligence (AI) that provides software and cloud solutions in simulation, high-performance computing (HPC), data analytics, and AI.

Houlihan Lokey Expands HCIT Coverage Capabilities

Retrieved on: 
Tuesday, August 9, 2022
Finance, Banking, Health, Professional Services, Health Insurance, Industry, NYSE, University of Chicago Booth School of Business, Acıbadem Healthcare Group, Houlihan, Lokey, Business, Bank, No, Universiade, Company, Houlihan Lokey, M&A, William Blair & Company, Culture, MBA, Faculdade de Medicina da Universidade Federal de Minas Gerais, University, Bank of America, SSA Global Technologies, Solution, Health care, Financial services, Refinitiv

Houlihan Lokey (NYSE:HLI), the global investment bank, announced today that Luiz Greca has joined the firms Healthcare Group as a Managing Director to lead the firms Healthcare IT (HCIT) practice in the U.S.

Key Points: 
  • Houlihan Lokey (NYSE:HLI), the global investment bank, announced today that Luiz Greca has joined the firms Healthcare Group as a Managing Director to lead the firms Healthcare IT (HCIT) practice in the U.S.
  • We are delighted that Luiz has joined us to lead our HCIT practice in the United States, particularly at a time when HCIT is among the most active segments of the healthcare M&A market.
  • Partnering Luiz with Frankfurt-based Raiko Stelten on our global HCIT coverage efforts will ensure a close collaboration between our market-leading industry groups to successfully deliver that domain expertise, along with the best advice and execution possible," said Phil Adams, Head of Global Technology at Houlihan Lokey.
  • Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and financial and valuation advisory.

Field Trial Success Drives Advancement in Asian Soybean Rust Resistance

Retrieved on: 
Wednesday, July 20, 2022
Group, Disease resistance, Isa, Biotechnology, Corteva, Soybean, Crop protection, Sainsbury Laboratory, Farmer, NYSE, Faculdade de Medicina da Universidade Federal de Minas Gerais, Agriculture, Partnership, Genetics, Solution, Risk, Multimedia, Organization, Gene, AG, Canker, ASR, Disease, Growth

EVANSTON, Ill., and INDIANAPOLIS, July 20, 2022 /PRNewswire/ -- Today, 2Blades and Corteva Agriscience announced they have reached a milestone in their collaboration to develop a transgene for Asian Soybean Rust (ASR) resistance with successful field trials of Latin American soybean varieties containing the new ASR transgene. This achievement marks an important point in the research collaboration between the two organizations, which seeks to develop durable resistance and minimize grower losses due to the plant pathogen.

Key Points: 
  • EVANSTON, Ill., and INDIANAPOLIS, July 20, 2022 /PRNewswire/ -- Today, 2Blades and Corteva Agriscience announced they have reached a milestone in their collaboration to develop a transgene for Asian Soybean Rust (ASR) resistance with successful field trials of Latin American soybean varieties containing the new ASR transgene.
  • "Results from the trial showed strong disease resistance in the transgenic soybean varieties tested," said Dr. Tom Greene, Biotechnology Leader at Corteva Agriscience.
  • 2Blades' knowledge of disease resistance, combined with Corteva's laboratory and field testing proficiency, as well as product development expertise, prompted the initial decision to collaborate in 2013.
  • While scientific advancements have led to some improvements in soybean rust control in countries such as Brazil, durable genetic resistance is an important tool for farmers to mitigate the risk of the disease.

SIUE Research on "Clumsy" Pumpkin Toadlets Gains International Attention

Retrieved on: 
Tuesday, June 21, 2022
Doctor of Philosophy, Time, Association, University, American Association, Friction, Pumpkin toadlet, Research Institute for Advanced Computer Science, Science Advances, SIUE, Locomotion, Biology, Faculty, Semicircular canals, Southeast Missouri State University, Florida Museum of Natural History, Faculdade de Medicina da Universidade Federal de Minas Gerais, Andrew King (neurophysiologist), Ohio University, Edge Hill University, Student, Research, Human, Universiade, American Association for Laboratory Animal Science, Natural history, Acceleration, Clumsy, SIUE College of Arts and Sciences, Southern Illinois University, Twitter, Adult, Vertebrate, Movement, Posture, Mississippi River, Medicine, Science

EDWARDSVILLE, Ill., June 21, 2022 /PRNewswire-PRWeb/ -- A small frog is making big headlines thanks to the intriguing findings of researchers, led by Southern Illinois University Edwardsville's Richard Essner, PhD.

Key Points: 
  • Now, brightly colored Pumpkin Toadlets and the researchers' findings are taking Twitter by storm.
  • Additionally, Science Advances' metric measuring attention on research places the scholarship among the top 5% ever, with related headlines spanning more than nine countries.
  • "We discovered that this group of miniaturized frogs from Brazil, known as Pumpkin Toadlets, are unable to control their landings," Essner said.
  • Pumpkin Toadlets and other miniaturized frogs have the smallest semicircular canals known among adult vertebrates.